Oct 17, 2022

Cordis Announces Acquisition of MedAlliance

Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology

Read more

Jul 11, 2022

Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe

Multi-center study to evaluate safety and efficacy of S.M.A.R.T. RADIANZ^™ Vascular Stent System via Radial Access

Read more

Jul 7, 2022

Cordis Names Bryan Loo President Of The Asia-Pacific Region

Bryan Loo will head a leadership team responsible for the fast-growing APAC region for Cordis.

Read more

Jun 14, 2022

Cordis Announces Successful First-in-Human Use of the Radianz Radial Peripheral System™

Read more

Jun 13, 2022

Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable IVC Filter

Signals continued investment in accelerated cardiovascular technology development

Read more

Jun 6, 2022

Coronary Angiography and PCI During Contrast Shortages

Presented by Dr. Darshan Doshi

Read more

May 26, 2022

Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Cordis Pays Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Read more

Apr 5, 2022

Cordis Makes Strategic Investment in E2

Cordis Makes Strategic Investment in E2, a developer of Next-Generation Thrombectomy Devices Move signals new chapter of innovation for Cordis

Read more

Mar 17, 2022

S.M.A.R.T. RADIANZ Vascular Stent System Approved for Transradial Use in the U.S.

The Radianz Radial Peripheral System(TM); signals Cordis’ renewed investment in innovation

Read more